{"id":"https://openalex.org/W2739681856","doi":"https://doi.org/10.1158/1538-7445.am2017-2628","title":"Abstract 2628: BGB-A425: a humanized anti-human Tim-3 antibody that exhibits strong immune cell activation","display_name":"Abstract 2628: BGB-A425: a humanized anti-human Tim-3 antibody that exhibits strong immune cell activation","publication_year":2017,"publication_date":"2017-07-01","ids":{"openalex":"https://openalex.org/W2739681856","doi":"https://doi.org/10.1158/1538-7445.am2017-2628","mag":"2739681856"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2017-2628","doi":"https://doi.org/10.1158/1538-7445.am2017-2628","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2017-2628","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008509353","display_name":"Tong Zhang","orcid":"https://orcid.org/0009-0005-7889-1506","observed_orcids":["https://orcid.org/0009-0005-7889-1506","https://orcid.org/0000-0002-9657-5129"]},"institutions":[{"id":"https://openalex.org/I4210100450","display_name":"BeiGene (China)","ror":"https://ror.org/012v2c923","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210100450"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Tong Zhang","raw_affiliation_strings":["BeiGene, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BeiGene, Beijing, China","institution_ids":["https://openalex.org/I4210100450"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100372191","display_name":"Xue Liu","orcid":"https://orcid.org/0000-0002-3491-0454","observed_orcids":["https://orcid.org/0000-0002-3491-0454"]},"institutions":[{"id":"https://openalex.org/I4210100450","display_name":"BeiGene (China)","ror":"https://ror.org/012v2c923","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210100450"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Liu Xue","raw_affiliation_strings":["BeiGene, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BeiGene, Beijing, China","institution_ids":["https://openalex.org/I4210100450"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101493583","display_name":"Jing Zhang","orcid":"https://orcid.org/0000-0002-8651-7638","observed_orcids":["https://orcid.org/0000-0002-8651-7638"]},"institutions":[{"id":"https://openalex.org/I4210100450","display_name":"BeiGene (China)","ror":"https://ror.org/012v2c923","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210100450"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jing Zhang","raw_affiliation_strings":["BeiGene, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BeiGene, Beijing, China","institution_ids":["https://openalex.org/I4210100450"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103145809","display_name":"Qi Liu","orcid":"https://orcid.org/0000-0001-6273-9351","observed_orcids":["https://orcid.org/0000-0001-6273-9351"]},"institutions":[{"id":"https://openalex.org/I4210100450","display_name":"BeiGene (China)","ror":"https://ror.org/012v2c923","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210100450"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Qi Liu","raw_affiliation_strings":["BeiGene, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BeiGene, Beijing, China","institution_ids":["https://openalex.org/I4210100450"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109725125","display_name":"Jie Ma","orcid":"https://orcid.org/0000-0002-5384-2987","observed_orcids":["https://orcid.org/0000-0002-5384-2987"]},"institutions":[{"id":"https://openalex.org/I4210100450","display_name":"BeiGene (China)","ror":"https://ror.org/012v2c923","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210100450"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jie Ma","raw_affiliation_strings":["BeiGene, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BeiGene, Beijing, China","institution_ids":["https://openalex.org/I4210100450"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100388145","display_name":"Yi Zhang","orcid":"https://orcid.org/0000-0002-3456-2728","observed_orcids":["https://orcid.org/0000-0002-3456-2728"]},"institutions":[{"id":"https://openalex.org/I4210100450","display_name":"BeiGene (China)","ror":"https://ror.org/012v2c923","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210100450"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yi Zhang","raw_affiliation_strings":["BeiGene, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BeiGene, Beijing, China","institution_ids":["https://openalex.org/I4210100450"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113817479","display_name":"Yingdi Shi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100450","display_name":"BeiGene (China)","ror":"https://ror.org/012v2c923","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210100450"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yingdi Shi","raw_affiliation_strings":["BeiGene, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BeiGene, Beijing, China","institution_ids":["https://openalex.org/I4210100450"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007210409","display_name":"Hongjia Hou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100450","display_name":"BeiGene (China)","ror":"https://ror.org/012v2c923","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210100450"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Hongjia Hou","raw_affiliation_strings":["BeiGene, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BeiGene, Beijing, China","institution_ids":["https://openalex.org/I4210100450"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014860072","display_name":"Hao Fan Peng","orcid":"https://orcid.org/0000-0003-1915-6104","observed_orcids":["https://orcid.org/0000-0003-1915-6104"]},"institutions":[{"id":"https://openalex.org/I4210100450","display_name":"BeiGene (China)","ror":"https://ror.org/012v2c923","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210100450"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Hao Peng","raw_affiliation_strings":["BeiGene, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BeiGene, Beijing, China","institution_ids":["https://openalex.org/I4210100450"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100648876","display_name":"Ning Liu","orcid":"https://orcid.org/0000-0003-0337-5409","observed_orcids":["https://orcid.org/0000-0003-0337-5409"]},"institutions":[{"id":"https://openalex.org/I4210100450","display_name":"BeiGene (China)","ror":"https://ror.org/012v2c923","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210100450"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ning Liu","raw_affiliation_strings":["BeiGene, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BeiGene, Beijing, China","institution_ids":["https://openalex.org/I4210100450"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Yilu Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100450","display_name":"BeiGene (China)","ror":"https://ror.org/012v2c923","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210100450"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yilu Zhang","raw_affiliation_strings":["BeiGene, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BeiGene, Beijing, China","institution_ids":["https://openalex.org/I4210100450"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013074988","display_name":"Xiaomin Song","orcid":"https://orcid.org/0000-0002-2586-9285","observed_orcids":["https://orcid.org/0000-0002-2586-9285"]},"institutions":[{"id":"https://openalex.org/I4210100450","display_name":"BeiGene (China)","ror":"https://ror.org/012v2c923","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210100450"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xiaomin Song","raw_affiliation_strings":["BeiGene, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BeiGene, Beijing, China","institution_ids":["https://openalex.org/I4210100450"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Yucheng Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100450","display_name":"BeiGene (China)","ror":"https://ror.org/012v2c923","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210100450"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yucheng Li","raw_affiliation_strings":["BeiGene, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BeiGene, Beijing, China","institution_ids":["https://openalex.org/I4210100450"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085999831","display_name":"Jing Song","orcid":"https://orcid.org/0000-0003-3771-8692","observed_orcids":["https://orcid.org/0000-0003-3771-8692"]},"institutions":[{"id":"https://openalex.org/I4210100450","display_name":"BeiGene (China)","ror":"https://ror.org/012v2c923","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210100450"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jing Song","raw_affiliation_strings":["BeiGene, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BeiGene, Beijing, China","institution_ids":["https://openalex.org/I4210100450"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030513449","display_name":"Lai Wang","orcid":"https://orcid.org/0000-0002-3323-7210","observed_orcids":["https://orcid.org/0000-0002-3323-7210"]},"institutions":[{"id":"https://openalex.org/I4210100450","display_name":"BeiGene (China)","ror":"https://ror.org/012v2c923","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210100450"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Lai Wang","raw_affiliation_strings":["BeiGene, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BeiGene, Beijing, China","institution_ids":["https://openalex.org/I4210100450"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Min Wei","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100450","display_name":"BeiGene (China)","ror":"https://ror.org/012v2c923","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210100450"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Min Wei","raw_affiliation_strings":["BeiGene, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BeiGene, Beijing, China","institution_ids":["https://openalex.org/I4210100450"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5104273343","display_name":"Kang Li","orcid":"https://orcid.org/0009-0004-9567-5146","observed_orcids":["https://orcid.org/0009-0004-9567-5146","https://orcid.org/0009-0007-6642-3259"]},"institutions":[{"id":"https://openalex.org/I4210100450","display_name":"BeiGene (China)","ror":"https://ror.org/012v2c923","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210100450"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Kang Li","raw_affiliation_strings":["BeiGene, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BeiGene, Beijing, China","institution_ids":["https://openalex.org/I4210100450"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210100450"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"77","issue":"13_Supplement","first_page":"2628","last_page":"2628"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9477999806404114,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9477999806404114,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.018200000748038292,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.01140000019222498,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tim-3","display_name":"TIM-3","score":0.8500000238418579},{"id":"https://openalex.org/keywords/anti-tim-3-antibody","display_name":"anti-TIM-3 antibody","score":0.8389999866485596},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.6869999766349792},{"id":"https://openalex.org/keywords/humanized-antibody","display_name":"humanized monoclonal antibody","score":0.7379999756813049},{"id":"https://openalex.org/keywords/galectin-9","display_name":"galectin-9","score":0.9440000057220459},{"id":"https://openalex.org/keywords/t-cell-exhaustion","display_name":"T cell exhaustion","score":0.7490000128746033},{"id":"https://openalex.org/keywords/nk-cell-cytotoxicity","display_name":"NK cell cytotoxicity","score":0.8949999809265137},{"id":"https://openalex.org/keywords/interferon-gamma-production","display_name":"IFN-gamma production","score":0.8080000281333923},{"id":"https://openalex.org/keywords/allogeneic-mixed-lymphocyte-reaction","display_name":"allogeneic mixed lymphocyte reaction","score":0.7710000276565552},{"id":"https://openalex.org/keywords/anti-pd-1-combination-therapy","display_name":"anti-PD-1 combination therapy","score":0.8149999976158142},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.546999990940094}],"concepts":[{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5786197781562805},{"id":"https://openalex.org/C139770010","wikidata":"https://www.wikidata.org/wiki/Q1339807","display_name":"Internalization","level":3,"score":0.572664201259613},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4943544864654541},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.47224491834640503},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4586688280105591},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4408855736255646},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.4400048851966858},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.42654645442962646},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.42619752883911133},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.38535887002944946},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3236203193664551},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.23168128728866577},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2274373471736908}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2017-2628","doi":"https://doi.org/10.1158/1538-7445.am2017-2628","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2017-2628","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.49000000953674316}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4366318089","https://openalex.org/W2068721292","https://openalex.org/W4225584766","https://openalex.org/W2145545797","https://openalex.org/W2764950946","https://openalex.org/W2952148578","https://openalex.org/W1807798123","https://openalex.org/W2014118959","https://openalex.org/W1585685362","https://openalex.org/W2009594705"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Tim-3":[2,30,148,168,219,306],"(T-cell":[3],"immunoglobin":[4],"and":[5,26,76,80,92,113,120,156,169,182,253],"mucin-domian":[6],"containing-3)":[7],"is":[8,14,55],"a":[9,56,159,189,235,303],"\u201ccheckpoint\u201d":[10],"inhibitory":[11],"receptor,":[12],"which":[13],"primarily":[15],"expressed":[16],"in":[17,46,74,77,202,227,234,251,254],"activated":[18],"or":[19,37,201],"\u201cexhausted\u201d":[20],"T":[21,180],"cells,":[22,24],"NK":[23],"macrophages":[25],"DCs.":[27],"Engagement":[28],"of":[29,42,51,69,99,126,146,178,218,263,317],"receptor":[31,107,220],"by":[32,89,117],"its":[33,257],"ligand":[34],"phosphatidylserine":[35],"(PtdSer)":[36],"galectin-9":[38],"leads":[39],"to":[40,103,142,196,245],"activation":[41,313],"negative":[43],"regulatory":[44],"signaling":[45],"T-cells,":[47],"promoting":[48],"functional":[49],"exhaustion":[50],"tumor-infiltrating":[52],"T-lymphocytes.":[53],"BGB-A425":[54,70,82,100,127,140,162,173,192,212,226,241],"novel":[57],"humanized":[58,88,304],"IgG1":[59],"(variant)":[60],"anti-Tim-3":[61],"antibody":[62,207,307],"under":[63],"preclinical":[64],"development.":[65],"The":[66,95,110,123],"immunomodulatory":[67,124],"activity":[68,244],"was":[71,83,101],"evaluated":[72,129],"both":[73,250],"vitro":[75,252],"vivo.":[78],"Materials":[79],"methods:":[81],"generated":[84],"through":[85],"hybridoma":[86],"fusion,":[87],"CDR":[90],"grafting":[91],"structural":[93],"simulation.":[94],"Fc":[96,105],"region":[97],"(IgG1)":[98],"engineered":[102],"remove":[104],"gamma":[106],"(Fc\u03b3R)":[108],"binding.":[109],"binding":[111],"affinity":[112,151],"specificity":[114],"were":[115,128],"studied":[116],"ELISA,":[118],"FACS":[119],"SPR":[121],"(Biacore).":[122],"functions":[125],"using":[130],"primary":[131,179],"immune":[132,247,311],"cells":[133,181],"as":[134,136],"well":[135],"cell":[137,222,248,312],"lines.":[138],"Results:":[139],"binds":[141],"the":[143,165,216,261,318],"extracellular":[144],"domain":[145],"human":[147,264],"with":[149,204,229],"high":[150],"(KD":[152],"=":[153],"0.36":[154],"nM)":[155],"specificity.":[157],"In":[158,171,188,224],"competition":[160],"assay,":[161,191],"efficiently":[163],"blocks":[164],"interactions":[166],"between":[167],"PtdSer.":[170],"vitro,":[172],"significantly":[174],"enhances":[175],"IFN-\u03b3":[176],"production":[177],"NK-mediated":[183],"cytotoxicity":[184],"against":[185],"tumor":[186,232],"cells.":[187],"MLR":[190],"augments":[193],"T-cell":[194],"response":[195],"allogeneic":[197],"antigens":[198],"either":[199],"alone":[200],"combination":[203,228],"an":[205],"anti-PD-1":[206],"BGB-A317.":[208],"Besides":[209],"blocking":[210],"Tim-3,":[211],"can":[213],"also":[214],"induce":[215],"internalization":[217],"on":[221],"surface.":[223],"vivo,":[225,255],"BGB-A317":[230],"inhibits":[231],"growth":[233],"mouse":[236],"xenograft":[237],"cancer":[238],"model.":[239],"Conclusions:":[240],"demonstrates":[242],"potent":[243],"stimulate":[246],"function":[249],"supporting":[256],"clinical":[258],"development":[259],"for":[260,321],"treatment":[262],"cancers.":[265],"Citation":[266],"Format:":[267],"Tong":[268],"Zhang,":[269,273,279,289],"Liu":[270],"Xue,":[271],"Jing":[272,294],"Qi":[274],"Liu,":[275,287],"Jie":[276],"Ma,":[277],"Yi":[278],"Yingdi":[280],"Shi,":[281],"Hongjia":[282],"Hou,":[283],"Hao":[284],"Peng,":[285],"Ning":[286],"Yilu":[288],"Xiaomin":[290],"Song,":[291,295],"Yucheng":[292],"Li,":[293],"Lai":[296],"Wang,":[297],"Min":[298],"Wei,":[299],"Kang":[300],"Li.":[301],"BGB-A425:":[302],"anti-human":[305],"that":[308],"exhibits":[309],"strong":[310],"[abstract].":[314],"In:":[315],"Proceedings":[316],"American":[319],"Association":[320],"Cancer":[322,335],"Research":[323],"Annual":[324],"Meeting":[325],"2017;":[326],"2017":[327],"Apr":[328],"1-5;":[329],"Washington,":[330],"DC.":[331],"Philadelphia":[332],"(PA):":[333],"AACR;":[334],"Res":[336],"2017;77(13":[337],"Suppl):Abstract":[338],"nr":[339],"2628.":[340],"doi:10.1158/1538-7445.AM2017-2628":[341]},"counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2025-10-10T00:00:00"}